Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cortria
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cortria

Cortria

Public

Cortria Corp: A US-based pharmaceutical company specializing in cardiovascular disease treatments.

HQ
Boston, MA, US
Founded
2005
Overview
Compare
Fundraising
Employees

Cortria Corporation is a pharmaceutical company focused on developing medications for cardiovascular diseases, particularly dyslipidemia. The company aims to provide innovative treatments to improve heart health and offers its services throughout the United States.

Cortria has made significant strides in the pharmaceutical industry by advancing its research and development efforts. The company's impact is evident in its commitment to addressing critical cardiovascular health issues, contributing to the well-being of patients nationwide.

Cortria - Similar Companies

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Corridor Pharmaceuticals logo

Corridor Pharmaceuticals

Corcept Therapeutics logo

Corcept Therapeutics

corcept.com

PharmRight logo

PharmRight

CSR Pharma Group logo

CSR Pharma Group

csrpharmsvcs.com

Cormedics logo

Cormedics

cormedicscorp.com

New American Therapeutics logo

New American Therapeutics

newamericantx.com

Sequel Pharmaceuticals logo

Sequel Pharmaceuticals

sequelpharma.com

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

TheraVasc logo

TheraVasc

China PharmaHub logo

China PharmaHub

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Anexon logo

Anexon

PleoPharma logo

PleoPharma

pleopharma.com

Corsair Pharma logo

Corsair Pharma

corsairpharma.com

Cortria - Quick Facts

Who are Cortria's competitors?

Companies similar to Cortria include Cardurion Pharmaceuticals, Corridor Pharmaceuticals, Corcept Therapeutics and PharmRight.

When was Cortria founded?

Cortria was founded in 2005.

Where is Cortria's headquarters located?

Cortria's headquarters is located in Boston, MA, US.

When was Cortria's last funding round?

Cortria's most recent funding round was for $1.8M (USD) in June 2009.

How much has Cortria raised to-date?

As of Jun 30, 2009, Cortria has raised a total of $1.8M (USD).

How many employees does Cortria have?

Cortria has 1 employee as of Feb 5, 2024.

Cortria - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medicines
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified